Brief: Moberg Pharma Enters Exclusive License Agreement With Karo Healthcare
05/11/2025 07:37
Nov 5 (Reuters) - Moberg Pharma AB (publ) MBPH.ST: MOBERG PHARMA AND KARO HEALTHCARE ENTER EXCLUSIVE LICENSE AGREEMENT FOR MOB-015/TERCLARA IN EUROPE, EXPANDING ACCESS AND GROWTH POTENTIAL AGREEMENT COVERS 19 EUROPEAN MARKETS UNDER LAMISIL BRAND AGREEMENT INCLUDES ROYALTIES AND COMPENSATION FOR PRODUCTS Source text: ID:nWkrhJvdj Further company coverage: MBPH.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))